Drug Eluting Balloons

Techniques in Vascular and Interventional Radiology

Volumn 13, Issue 1, 2010, Pages 59-63

  Diehm, Nicolas A ^a   Hoppe, Hanno ^b   Do, Dai Do ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

angioplasty; critical limb ischemia; paclitaxel; restenosis

Indexed keywords

NITINOL;

ARTERY OCCLUSION; BRACHYTHERAPY; DRUG ELUTING STENT; FEMOROPOPLITEAL OBSTRUCTION; HUMAN; MINIMALLY INVASIVE SURGERY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVASCULARIZATION; REVIEW; SWITZERLAND;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CARDIOVASCULAR AGENTS; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; HUMANS; LOWER EXTREMITY; PERIPHERAL VASCULAR DISEASES; PROSTHESIS DESIGN; RECURRENCE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 72149104072     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2009.10.008     Document Type: Review

References (13)

1. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 (2007) S5-S67
2. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
3. Schillinger M., Sabeti S., Dick P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007) 2745-2749
4. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
5. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J Vasc Interv Radiol 16 (2005) 331-338
6. Minar E., Pokrajac B., Ahmadi R., et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: Pilot study. Radiology 208 (1998) 173-179
7. Johnston K.W. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty. Radiology 183 (1992) 767-771
8. Nikanorov A., Smouse H.B., Osman K., et al. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg 48 (2008) 435-440
9. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
10. Siablis D., Karnabatidis D., Katsanos K., et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 14 (2007) 241-250
11. Scheller B., Speck U., Abramjuk C., et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110 (2004) 810-814
12. Tepe G., Zeller T., Albrecht T., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358 (2008) 689-699
13. Werk M., Langner S., Reinkensmeier B., et al. Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation 118 (2008) 1358-1365